Loading asset research
Indaptus Therapeutics Inc. Common Stock
INDPNasdaq · USD · StocksQuote as of · Exchange session not verified$2.77
+8.20%
Today
INDP
Loading 1D prices…
Market cap
$369.1M
Volume
1.8M
52w high
$8.5752w low
$0.92Company profile
Indaptus Therapeutics Inc. Common Stock
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
New York, NY, United States
Employees
5
Fiscal year end
1231
CIK
1857044
Session & valuation
Open$2.70
Previous close$2.56
Day high$2.94
Day low$2.46
30-day avg. volume1.2M
Outstanding shares133.2M
Diluted EPS-$21.58
Latest annual period
P/E (trailing)-0.13
P/E (forward)-1.99
Price / book32.59
Beta1.17
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| RCKTRocket Pharmaceuticals Inc. Common Stock | $367.7M | $0.00 | — | -$2.01 | -3.88% | Hold |
| PRLDPrelude Therapeutics Incorporated Common Stock | $366.3M | $12.1M | -819.60% | -$1.29 | -1.50% | Buy |
| ENTAEnanta Pharmaceuticals Inc. Common Stock | $377.5M | $50.1M | -88.82% | -$1.54 | +1.97% | Buy |
| EVMNEvommune Inc. Common Stock | $382.5M | $13M | -529.77% | -$11.22 | -0.19% | Buy |
| SIONSionna Therapeutics Inc. Common Stock | $354.4M | $0.00 | — | -$1.88 | +2.76% | Hold |